Blog

Agreement on Mutual Recognition between Canada and the European Community

In 1998, Canada and the European Community (EC) signed an Agreement on Mutual Recognition (MRA) which would allow the recognition of conformity assessment results between the two entities. This would effectively eliminate the need for duplicative testing and certification, as well as reduce technical barriers to trade.

The agreement covers a wide range of sectors including pharmaceutical, medical devices, telecommunications and electromagnetic compatibility, and automotive products. It also includes provisions for the recognition of testing and certification bodies, as well as accreditation bodies.

The MRA allows for the recognition of conformity assessment results from designated conformity assessment bodies located in Canada and the European Union. This streamlines the process for companies seeking to export products from one region to the other, reducing costs and time-to-market.

The agreement has been beneficial for both Canada and the EC. It has allowed companies from both regions to sell their products in each other`s markets more easily, which has led to increased trade and economic growth. In addition, the MRA has contributed to the development of international standards, as well as strengthened regulatory cooperation between the two regions.

The MRA has also had a positive impact on consumer safety. By recognizing each other`s conformity assessment results, Canada and the EC can be confident that products sold in their markets meet the same standards of safety and performance.

In conclusion, the Agreement on Mutual Recognition between Canada and the European Community has been a significant achievement in the realm of international trade. It has reduced technical barriers to trade, streamlined the process for exporting products, and contributed to the development of international standards. The MRA has also improved regulatory cooperation and increased consumer safety, making it a win-win for both regions.